drlauraesserman.bsky.social @drlauraesserman.bsky.social · 02/06/2026I had a fantastic time at the Brazilian Breast Cancer Symposium last month. Thank you to my gracious hosts for the hospitality and thank you to the committee for the honor! 010 0
drlauraesserman.bsky.social @drlauraesserman.bsky.social · 20/05/2025Judy Boughey's presidential address highlighted how important innovative trial design is for moving the field forward and talked about I SPY 2.2.- even though it is more complex, it is a wonderful way to treat patients 020 0
drlauraesserman.bsky.social @drlauraesserman.bsky.social · 20/05/2025Mandeep Kaur presenting on the disparity in the use of axillary dissection by race at ASBrS 2025 020 0
drlauraesserman.bsky.social @drlauraesserman.bsky.social · 20/05/2025Julie van Hassel (award for best trainee) presented on the time to surgery after neoadjuvant chemo and impact on outcomes (In the setting of excellent response, time is not important, but in setting of residual disease, > 9 weeks is associated with worse outcome) 020 0
drlauraesserman.bsky.social @drlauraesserman.bsky.social · 20/05/2025Rita Mukhtar and down staging of the axilla in lobular vs. ductal on I SPY at ASBrS 2025 032 0
drlauraesserman.bsky.social @drlauraesserman.bsky.social · 17/12/2024RISE UP taught us that BZA is perhaps one of the best agents to target endocrine positive tumors. We are really excited to be participating in a trial that is testing to see if BZA combined with a small amount of estrogen can be risk-reducing and at the same time relieve women of hot flashes. 110 0
